C37H5.16

Caenorhabditis elegans

Is affected by etr-1 and cox-5B based on RNA-seq studies.

anr-19

Caenorhabditis elegans

Is affected by cox-5B and nfki-1 based on RNA-seq studies.

F54H5.11

Caenorhabditis elegans

Is affected by set-2 and cox-5B based on RNA-seq studies.

F57B1.10

Caenorhabditis elegans

Is affected by cox-5B; glp-1; and ilc-17.1 based on RNA-seq studies.

M01H9.7

Caenorhabditis elegans

Is affected by several genes including kri-1; mpk-2; and cox-5B based on RNA-seq studies.

anr-51

Caenorhabditis elegans

Is affected by several genes including etr-1; cox-5B; and unc-70 based on RNA-seq studies.

anr-2

Caenorhabditis elegans

Is affected by several genes including mrps-5; cox-5B; and ogt-1 based on RNA-seq studies.

tat-5

Caenorhabditis elegans

Predicted to enable ATPase-coupled intramembrane lipid transporter activity. Involved in embryo development. Located in cytoplasmic vesicle and plasma membrane. Expressed widely. Human ortholog(s) of this gene implicated in neurodevelopmental disorder with poor growth and behavioral abnormalities. Is an ortholog of human ATP9B (ATPase phospholipid transporting 9B (putative)).

F23H12.21

Caenorhabditis elegans

Is affected by several genes including etr-1; mrps-5; and cox-5B based on RNA-seq and microarray studies.

F22E10.6

Caenorhabditis elegans

Is affected by several genes including mrps-5; cox-5B; and alh-4 based on RNA-seq and microarray studies.